Insight Molecular Diagnostic

Penny Stocks Biotech Stocks Healthcare Stocks

$3.18

-0.74 (-18.88%)

As of Sep 28, 10:15 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 8 73%

Hold 3 27%

Sell 0 0%

Price Target

Analyst Price Target +447.5% upside

Low Target $14.05

Average Target $17.41

High Target $26.42

Current Price $3.18

Current
$3.18

Target
$17.41

$14.05 $17.41 avg $26.42

Scenario Analysis

Bear Case

$14.05

341.8%

Low target

Base Case

$17.41

+447.5%

Avg target

Bull Case

$26.42

+730.8%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$8.51

-62.6% from high

52-Week Low

$2.42

+31.4% from low

Target vs 52W High

$17.41

+104.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%